Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Neuropharma 2017

Sessions/Tracks

Track 1: Neuropharmacology

Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology, behavioral and molecular. Both of these fields are closely connected, since both are concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Studying these interactions, researchers are developing drugs to treat many different neurological disorders, including pain, neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, psychological disorders, addiction, and many others.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 2: Molecular Neuropharmacology

Molecular neuropharmacology involves the study of neurons and agonist, Competitive antagonist and Non-competitive antagonist, receptors on neurons for developing new drugs that will treat neurological disorders of neurodegenerative diseases. Neurogenesis and repair refers to the growth and development of neuron. Neurons never function in isolation; they are organized into ensembles or circuits that process kinds of information which are referred as neuronal circuits.

The GABA inhibitory neurotransmitter and serotonin neurotransmitter present in the central nervous system of mature vertebrate interacts with GABA receptor and 5HT receptor respectively. GABAA receptors are modulated by the channel of 5HT receptors through activation of various proteins. There are about 14 5HT receptor subtypes identified from last 20 years which are now researched for their significance in various disorders and treatments. Synaptopathy is a progressively popular term used to define main features of psychiatric and neurodegenerative diseases. It infers that brain diseases are resulted from disruption of synaptic structure and function.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 3: Clinical Neuropharmacology

Clinical neuropharmacology covers a wide range of neurologic and a few psychiatric disorders, with an emphasis on clinical relevance. Unlike most neuropharmacology texts, it is organized according to specific clinical conditions rather than type of Neuropharmacological agent. It is the science that studies the features, properties, responses and uses of drugs mainly their therapeutic effect in humans along with toxicology, pharmacodynamics and pharmacokinetics. It also includes drug abuse, pain and hypothalamic releasing factors. Most frequently occurring neurologic disorders are included with a heavy emphasis on movement disorders.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 4: Psychopharmacology

Psychopharmacology is the learning of the effects of medication on the psyche (psychology), observing changed behaviors and how molecular events are manifest in a measurable behavioural form. Neurogenesis and repair deal with other aspects on the indications for medications prescribed to address psychiatric and behavioural problems, that are associated with, including antipsychotic, anxiolytic and anticonvulsant medications, acquired brain injury and psychopharmacology drugs and their interaction with neurotransmitters also include mood stabilizers and treatments prescribed for disorders of attention.

The treatments may cause side effects such as induction of the metabolic syndrome, type II diabetes related to the medications prescribed for management of psychiatric and behavioural disorders and disturbances. The effectiveness of the drugs can be increased by prescriber’s knowledge over emotional and interpersonal issues of the patient i.e. psychology of psychopharmacology. Schizophrenia is such a disorder which affects the thinking and acting ability of a person caused by viral infection, genetically or by immune disorder.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 5: Neurochemical Transmission

Neurochemistry is the specific study of neurochemicals, including neurotransmitters and other molecules that include psych pharmaceuticals, neuropeptides, or gastro transmitters that influence the function of neurons. It also deals how these neurochemicals influence the network of neural operation. The studies include micro-macro connection between the analysis of organic compounds active in the nervous system and neural processes such as cortical plasticity, neurogenesis and neural differentiation, synapses, autism and intellectual disability, interneuron coordination, interaction of drugs and its effect on summation and transmission process and advances in astrocyte-neuron interactions in health. Astrocyte dysfunction results into neurodegenerative diseases, stroke, epilepsy, migraine and neuro inflammatory diseases.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 6: Behavioral Neuropharmacology

It is the study of drug dependence and how drug addiction affects the human mind, Anxiety and Autism, Measuring neural activity in Drug abuse, Alcoholism- tolerance to and physical dependence, and properties are mediated through its effects on dopamine neurons in the mesolimbic reward pathway, which connects the ventral tegmental area to the nucleus acumens, Post-traumatic stress disorder and borderline personality disorder, clinical depression and enhanced treatments.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 7: Chemical Neurotransmitters

Neurotransmitters are endogenous, special messenger chemicals that enable neurotransmission. They transmit signals across a chemical synapse, such as a neuromuscular junction, from one neuron (nerve cell) to another "target" neuron, muscle cell, or gland cell. Neurotransmitters are released from synaptic vesicles in synapses into the synaptic cleft, where they are received by receptors on the target cells. Many neurotransmitters are synthesized from simple and plentiful precursors such as amino acids, which are readily available from the diet and only require a small number of biosynthetic steps for conversion.

They can also affect mood, sleep, concentration, weight, and can cause adverse symptoms when they are out of balance. These are of two types: Inhibitory and Excitatory. Acetylcholine, Glutamine and GABA are some of these neurotransmitters.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 8: Neuro Immune Pharmacology

It deals with a branch of immunology concerned with the interactions between immunological and nervous system functions also associated autoimmune diseases.  Cortical system involves the study of mapping neural systems associated in the processing of emotion, and it focuses on the cortical components of the process of recognizing facial expressions. Encephalitis is acute inflammation of the brain resulting from a viral infection or an autoimmune disease. Transverse myelitis is a pathogenically heterogeneous inflammatory disorder in which spinal cord is affected. Huntington disease is a progressive brain disorder that causes uncontrolled movements, emotional problems, and loss of thinking ability.

Blood brain barrier is a selectively permeable membrane that separates the blood in the brain from other extracellular fluids. Meningitis, epilepsy, cerebral edema, multiple sclerosis etc. are various diseases associated with it. The children of age group 1 to 14 are more prone to cancer, out of which 18% is the case of brain tumor. In the first three decades of life, central nervous system has emerged as one of the three vulnerable leading sites for cancer mortality. Cerebral lymphoma is the most rapidly increasing brain tumor. 

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 9: Neuroendocrinology

It is the study of interactions between the nervous system and the endocrine system, also biological features of the cells involved and their communications. Most Important aspects of neuroendocrinology are insulin receptor and hypothalamic programming; stress, coping and interactions, neuro-endocrine-immune symphony, pituitary structure and hormone secretion. Alzheimer's is a type of dementia that causes problems with memory, thinking and behaviour. Symptoms usually develop slowly and become severe enough to interfere with daily tasks. Amyloid plaques are also found in the brain of Alzheimer patients. Neurocognitive effects associated with therapeutic drugs and animal cognition and behaviour - Fear and aversive learning and memory.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 10: Parkinson’s Disease

It is a progressive and chronic disorder, caused by death or malfunctioning of neurons, genetic mutation leading to decreased level of dopamine secretion. It can cause neuropsychiatric disturbances that range from mild to severe. This includes disorders of speech, cognition, mood, behaviour, and thought. Mostly it is idiopathic (having no specific known cause) type. However, a small proportion of cases are known genetic factors. Other factors have been associated with the risk of developing PD, but no causal relationships have been proven. There is no cure for Parkinson's disease, but medications, surgery, and multidisciplinary management can provide relief from the symptoms.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 11: Neuroethics

It includes the social, legal and ethical consequences of advances in neuroscience. It is the amalgamation of neuroscience with ethical thoughts. The ethics of neurocognitive includes brain interventions and imagining, neurological treatments and consciousness disorders. Neuroethics encompasses a wide range of issues, which can only be sampled here. Some have close ties to traditional biomedical ethics, in that different versions of these issues can arise in connection with organ systems other than the brain. In contrast, many neuroethical issues are at least partly novel and this accounts for some of the intellectual fascination of neuroethics. These relatively newer issues force us to think about the relation between mind and brain and its ethical implications.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 12: Future Aspects of Neuropharmacology

Neuropharmacology is an emerging field of science, rising exponentially with the understanding of nervous system and its related disorders, drugs and treatments. The major area of research includes mechanisms of novel drugs, neuro stem cell therapy, immunoglobulin therapy, gene therapy in neuronal disorders and neural engineering. Ultrasound systems comprise 29% of the global medical imaging systems market. X-ray systems are next, with a 24% share. Positron emission tomography has seen growth but it is the smallest segment. The X-ray market is growing well due to the introduction of digital technology.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 13: Neuro Chemical Interaction

Neurons are known as excitable cells because on its surface membrane there are an abundance of proteins known as ion-channels that allow small charged particles to pass in and out of the cell. The structure of the neuron allows chemical information to be received by its dendrites, propagated through the perikaryon (cell body) and down its axon, and eventually passing on to other neurons through its axon terminal.

Neurotransmitter/receptor interactions in the field of neuropharmacology are extremely important because many drugs that are developed today have to do with disrupting this binding process.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 14: Latest Advancement in Neuropharmacological Therapy

The great advances made in the department of pharmacology have been placed in this session. A few new ones have been introduced but the most important additions have come chiefly from chemist laboratory. Chemists have gradually discovered methods to modify that composition by the introduction of new elements, and thus render these active principles more suitable and more effective for therapeutic employment.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 15: Case Study Reports

Case studies are extremely useful records of the clinical practices of a profession. They are a record of clinical interactions which help us to frame questions for more rigorously designed clinical studies. Case studies also provide valuable teaching material, demonstrating both classical and unusual presentations which may challenge the practitioner. Analysing a case study requires you to practice applying your knowledge and your thinking skills to a real situation. To learn from a case study analysis you will be “analysing, applying knowledge, reasoning and drawing conclusions.”

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

 

 

About Conference

Conference Series LLC  invites all the participants from all over the world to attend “10th International Conference on Neuropharmacology and Neuropharmaceuticals” during October 23-24, 2017 at Dubai, UAE which includes prompt Keynote Presentations, Oral talks, Poster Presentations and Exhibitions.

Neuropharma 2017 is the learning of how drugs influence cellular function in the nervous system, and the neural mechanisms through which they influence behaviour. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders, including neurodegenerative diseases known to be Parkinson's disease and Alzheimer's disease, pain, addiction, psychological disorders and many more. Conference Series LLC organizes a conference series of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With individuals from around the globe concentrated on finding out about neuropharmacology and its advances; this is your best chance to achieve the biggest collection of members from the Neuropharmacology people group. Lead presentations, disseminate data, meet with present and potential researchers, make a sprinkle with new medication advancements, and get name acknowledgment at this 2-day occasion. Widely acclaimed speakers, the latest procedures, advancements, and the most up to date overhauls in Neuropharmacology are signs of this gathering.

Target Audience:

  • Neuropharmacology Students
  • Scientists
  • Doctors
  • Neuropharmacology Researchers
  • Neuropharmacology Faculty
  • Toxicologist
  • Medical Colleges
  • Neuropharmacology Associations and Societies
  • Pharmacologists
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Science writers
  • Manufacturing Medical Devices Companies
  • Data Management Companies
  • Pharmaceutical Industrialists

Past Conference Report

Neuropharmacology 2016

Neuropharmacology 2016 Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Neuropharmacology 2016 Conference the best ever!

The 4th Global Experts Meeting on Neuropharmacology, hosted by the Conference Series LLC was held during September 14-16, 2016 at Hilton San Antonio Airport, San Antonio, USA based on the theme Innovations and Complications in Neuropharmacological Studies". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Neuropharmacology, who made this event a grand success.

Conference Series LLC expresses its gratitude to the conference Moderator, namely Dr. Reginald Lafleur and Phenix Alcide from Harlem Cardiology, USA for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

We are grateful to our Symposium and workshop organizers. The list comprises:

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Neuro Immune Pharmacology
  • Molecular Neuropharmacology
  • Psychopharmacology
  • Neurochemical Transmission
  • Behavioral Neuropharmacology
  • Neurotechnology
  • Neuroendocrinology
  • Alzheimer’s Disease and Dementia
  • Parkinson’s Disease
  • Neuroethics
  • Future Aspects of Neuropharmacology
  • Clinical Neuropharmacology
  • Chemical Neurotransmitters
  • Case Study Reports
  • Entrepreneurs Investment Meet

Conference Series LLC offers its heartfelt appreciation to organizations such as Bulgarian Society of NeurologyHuman Behavior Laboratory and our esteemed supporters KOWAFederation of all European Neuroscience Societies (FENS), MedtubeSchizophrenia International Research SocietySelectScience and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. Conference Series LLC also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Exhibitors who supported this event.

With the grand success of Neuropharmacology 2016Conference Series LLC is proud to announce the "7th Global Experts Meeting on Neuropharmacology" to be held during July 31-Aug 02, 2017 at Rome, Italy

For More details visit: http://neuro.pharmaceuticalconferences.com/


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date Oct 23-24, 2017

For Sponsors & Exhibitors

Sponsorship Opportunities

Speaker Opportunity

Supported By

Neurochemistry & Neuropharmacology: Open Access Journal of Neurological Disorders Journal of Neurology & Neurophysiology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by